Skip to content

Comparing the Stanford Letter Project Form to Traditional Advance Directives

Comparing the Stanford Letter Project Form to Traditional Advance Directives

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02799537
Acronym
SLP
Enrollment
1000
Registered
2016-06-15
Start date
2016-02-29
Completion date
2026-12-31
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Directives, Palliative Care

Keywords

supportive care, palliative care, goals of care, advance care planning, advance directives

Brief summary

Our goal is to compare two types of advance directives forms available in English and Spanish to determine which is more easy to use for patients.

Detailed description

Step1: Any adult participant who is interested in completing advance directives and able to read and write in English and or Spanish will be eligible to participate in the study Step 2: Online Stanford consent form will be presented before the participants. Only after they read the consent and click on the participation link will they be able to enter the study.Those who are willing to participate will be randomly assigned to either the letter or traditional advance directives in Spanish and study measures. They will also answer questions as to how much they liked and understood the documents. Step 4: The investigators will collect data until the investigators reach an n=1000 Step 5: The investigators will analyze the results and submit for publication. In this protocol, we are assessing whether patients prefer the traditional advance directives or the letter directive. As it is just an questionnaire based study, there no risk for patients.

Interventions

OTHERRandomized clinical study

Participants will be randomly assigned to one of two advance directives and we will assess which they prefer. This is not a human health intervention

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 years of age

Exclusion criteria

* Under 18

Design outcomes

Primary

MeasureTime frameDescription
Ease of use of Questionnaire. more patient-centered and family oriented1yearIt was easy to read and understand the form of advance directive .◦This is a feasibility trail. On completion of the advance directive they were assigned ( letter directive or traditional directive, we are asking questions to participants about whether the directive was clear and easy to understand).

Secondary

MeasureTime frameDescription
Ease of use about the type of treatment and care.1yearAdvance form stimulated my own thinking about the type of treatment and care they wish to receive in my last days of life.
Ease of use about letting my doctors about my wishes.1 yearThis form can help my doctors understand what treatments would like to receive and what not wish to receive in my last days of life ( resuscitation , respirators , artificial feeding , renal dialysis).
Ease of use if I cannot make decisions for myself then the form says it.1 yearIn the future, if I can not make decisions for myself, this form will help my family / friends understand exactly what treatments ( resuscitation , respirators , artificial feeding , renal dialysis) would like to receive and what treatments do not wish to receive so they can make decisions medical for me.
Ease of use to describe how decisions are made1yearAdvance form helped me to describe how decisions are made
Ease of use of the form itself.1 yearI feel comfortable using form for advance care planning .
Ease of use and the comments participants may have.1 yearAny comments participants may have about the form of advance directive ? What can investigators do for patients and their families understand it better?
Ease of use about my future preferences.1 yearThere were issues with my future preferences that were not covered in the form of advance directive .

Countries

United States

Contacts

Primary ContactVJ Periyakoil, MD
Periyakoil@stanford.edu(650) 493-5000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026